223 related articles for article (PubMed ID: 166941)
1. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
3. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
[TBL] [Abstract][Full Text] [Related]
5. Enzyme-linked immunosorbent assay for the detection of Epstein-Barr virus-induced antigens and antibodies.
Sternås L; Luka J; Kallin B; Rosén A; Henle W; Henle G; Klein G
J Immunol Methods; 1983 Oct; 63(2):171-85. PubMed ID: 6311908
[TBL] [Abstract][Full Text] [Related]
6. Column separation of viral capsid antigen (VCA)-positive cells from VCA-negative cells in an Epstein-Barr virus (EBV)-producing lymphoid line,
Dalianis T; Klein G; Andersson B
Int J Cancer; 1977 Apr; 19(4):460-7. PubMed ID: 191413
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
8. Production of rabbit antibodies against the viral capsid antigen (VCA) of the Epstein-Barr virus (EBV).
Vestergaard BF; Hesse J; Norrild B; Klein G
Int J Cancer; 1978 Mar; 21(3):323-8. PubMed ID: 75856
[TBL] [Abstract][Full Text] [Related]
9. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
10. Detection of antibodies to Epstein-Barr virus antigens by enzyme-linked immunosorbent assay.
Hopkins RF; Witmer TJ; Neubauer RH; Rabin H
J Infect Dis; 1982 Dec; 146(6):734-40. PubMed ID: 6183369
[TBL] [Abstract][Full Text] [Related]
11. The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement.
Liabeuf A; Nelson RA; Kourilsky FM
Int J Cancer; 1975 Apr; 15(4):533-46. PubMed ID: 166939
[TBL] [Abstract][Full Text] [Related]
12. Antigen-inducing ability of herpesvirus papio in human and baboon lymphoma lines, compared to Epstein-Barr virus.
Klein G; Falk L; Falk K
Intervirology; 1978; 10(3):153-64. PubMed ID: 210135
[TBL] [Abstract][Full Text] [Related]
13. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
14. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
Giunta S; Groppa G
Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
[TBL] [Abstract][Full Text] [Related]
15. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
16. The variability in immunofluorescent viral capsid antigen antibody tests in population surveys of Epstein-Barr virus infections.
Geser A; Day NE; de-Thé GB; Chew BK; Freund RJ; Kwan HC; Lavoue MF; Simkovic D; Sohier R
Bull World Health Organ; 1974; 50(5):389-400. PubMed ID: 4376066
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus.
Klein G; Dombos L; Gothoskar B
Int J Cancer; 1972 Jul; 10(1):44-57. PubMed ID: 4122458
[No Abstract] [Full Text] [Related]
18. Epstein-barr Virus (EBV) intracellular antigens: factors affecting the patterns of immunofluorescence.
Favart AM; Lamy ME; Burtonboy G
Arch Virol; 1980; 65(3-4):337-46. PubMed ID: 6251788
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to Epstein-Barr virus-associated nuclear antigen and to other viral and non-viral antigens in Hodgkin's disease.
Rocchi G; Tosato G; Papa G; Ragona G
Int J Cancer; 1975 Aug; 16(2):323-8. PubMed ID: 168161
[TBL] [Abstract][Full Text] [Related]
20. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
[No Abstract] [Full Text] [Related]
[Next] [New Search]